Examination Report |
1 | Additional Representation Sheet | 11 Jan 2011 |
10 | Journal Copy | 06 Feb 2018 |
11 | Certificate | 06 Mar 2018 |
12 | TM-R(RENEWAL OF TRADE MARK) | 10 Nov 2020 |
13 | TM-P(SUBSEQUENT PROPRIETOR BY WAY OF ASSIGNMENT OR TRANSFER OF A SINGLE MARK) | 02 Aug 2023 |
14 | Notices | 08 Mar 2024 |
15 | Letters related to POST REGISTRATION | 24 Jul 2024 |
2 | Correspondence | 11 Jan 2011 |
3 | TM-1 | 11 Jan 2011 |
4 | Authorization Document (POA) | 11 Jan 2011 |
5 | Correspondence | 12 Jan 2011 |
6 | Correspondence | 20 Jan 2011 |
7 | Correspondence | 20 Mar 2011 |
8 | Reply to Exam Report (MIS-R) | 10 Apr 2012 |
9 | Hearing Notice | 04 Oct 2017 |
1 | Hearing Notice (Show Cause) | 5046803 | 19 Aug 2017 | |
2 | Tribunal ABA Notice for : 2083485 | 5183263 | 04 Oct 2017 | |
3 | RENEWAL INTIMATION LETTER | 10687838 | 13 Nov 2020 |
Trademark was applied on 11 January 2011 with IP India.
Proprietor of Benadryl cr is JOHNSON JOHNSON.
Class(es) in which the trademark was applied to is 5.
Status of Benadryl cr is Registered.
Application number alloted to the trademark is 2083485.
Lall & Sethi is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD